Controversial Report Challenges Gender-Affirming Care for Youth
In a move that has reignited debates over medical ethics and transgender youth care, the U.S. Department of Health and Human Services (HHS) unveiled a comprehensive 400-page report critically examining the current approach to treating pediatric gender dysphoria. The report’s conclusions have stirred reactions from both supporters and detractors of gender-affirming care practices.
The document, titled “Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices,” has refrained from disclosing its authors to maintain the “integrity” of a post-publication peer review process. This decision was communicated in a recent HHS press release. However, details such as the number of contributors or their affiliations remain undisclosed, raising questions about transparency.
The predominant U.S. medical approach involves affirming a child’s gender identity and potentially offering medical interventions like puberty blockers. This method, supported by leading medical associations, faces scrutiny in the report for allegedly neglecting the health interests of young patients.
White House Deputy Chief of Staff Stephen Miller, during a press briefing, described interventions for gender dysphoria as “barbaric,” stating, “They violate all sound medical ethics. They are completely unwarranted. They harm children for life irreversibly. It is child torture. It is child abuse. It is medical malpractice.”
Dr. Susan Kressly, president of the American Academy of Pediatrics, expressed profound concern over the report, calling it “deeply alarming” and claiming it misrepresents the medical consensus by relying on “select perspectives and a narrow set of data.” Kressly emphasized that the report inaccurately portrayed the AAP’s recommendations, which advocate for “comprehensive, gender-affirming, and developmentally appropriate health care.”
The report stems from an executive order titled “Protecting Children From Chemical and Surgical Mutilation,” which criticizes medical procedures aimed at altering a child’s sex as being irreversible and harmful.
Under President Trump’s administration, significant resources, exceeding $200 million, have been allocated to campaigns opposing transgender rights. The administration’s initiatives include restricting transgender participation in sports and military service and altering passport policies to reflect sex at birth. Some of these measures have faced legal challenges.
Despite the report’s claims of over-accessibility to transition-related care, more than half of U.S. states have enacted bans, with the Supreme Court set to decide on a Tennessee case this spring. The HHS report draws parallels to the U.K.’s Cass Review, which also questions the benefits of gender-affirming care.
An anonymous physician providing gender-affirming care criticized the report, labeling it “propaganda” with a premeditated agenda. The doctor argued that its authors dismiss the legitimacy of transgender identity, aiming to curtail the autonomy of trans individuals.
Meanwhile, Kristen Waggoner of the Alliance Defending Freedom commended the report, advocating for the closure of gender clinics and suggesting legal actions against involved medical practitioners.
